PROLIA 60MG INJECTION

Prolia 60mg injection is composed of the active component Denosumab. It is a drug that treats osteoporosis, characterized by weak bones. It’s also used to avoid bone problems in patients with certain forms of cancers, like bone metastases and myeloma. Prolia 60mg Injection functions by inhibiting a protein known as RANK Ligand, which is involved in degrading bone tissue. Research has shown that it can boost bone density while reducing the risk of breaking in postmenopausal females who have osteoporosis, as well as patients suffering from the loss of bone due to cancer. A close monitoring of renal function is recommended for patients suffering from moderate impairment in their renal function.
Prolia 60mg Injection shouldn’t be administered to patients with known allergies or hypersensitivity to its constituents. Proper vitamin D and calcium supplementation intake is essential to maintain the course of treatment. It is not a medical device that has been approved to be used in children and adolescents. The safety and efficacy of this medication in children have not been proven. Therefore, it is not recommended for people under the age of 18. The medication should be utilized carefully in patients with pre-existing hypoparathyroidism that is which is characterized by low levels of parathyroid hormone.